Bioverge
Early Stage
Bioverge is an investment platform that funds visionary entrepreneurs with the aim of transforming healthcare and bringing science fiction to life.
Overview
Raised: $710,266
Total Commitments ($USD)
Platform
Netcapital
Start Date
05/14/2021
Close Date
02/28/2022
Min. Goal
$10,000
Max. Goal
$1,069,999
Min. Investment
$99
Security Type
Equity - Common
Series
Pre-Seed
SEC Filing Type
RegCF
Price Per Share
$1.14
Pre-Money Valuation
$10,014,900
Rolling Commitments ($USD)
Status
Funded
Reporting Date
03/06/2022
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$2,449
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2017
Industry
Financial & Insurance Products & Services
Tech Sector
Fintech
Distribution Model
B2B/B2C
Margin
Medium
Capital Intensity
Low
Bioverge, with a post-money valuation of $11 million, is raising funds on NetCapital. It is an investment platform that funds entrepreneurs with the aim to transform healthcare. The platform allows both accredited and non-accredited investors to invest in healthcare startups and support them. Neil J. Littman and Rick Gibb founded Bioverge in 2017. The current crowdfunding round has a minimum raise of $10,000 and a maximum raise of $1,069,999, and the funds will be used for product development, sales and marketing, and general and administrative expenses. Bioverge has successfully closed 32 deals across 21 portfolio companies.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$68,795 |
$24,047 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-432,913 |
$-161,357 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$570,343 |
$266,383 |
|
Accounts Receivable |
$7,034 |
$4,997 |
|
Total Assets |
$975,622 |
$544,624 |
|
Short-Term Debt |
$123,702 |
$123,702 |
|
Long-Term Debt |
$1,363,520 |
$588,520 |
|
Total Liabilities |
$1,487,222 |
$712,222 |
Financials as of: 05/14/2021
Create a free account today to gain access to KingsCrowd analytics.
Raise History
| Offering Name | Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|---|
| Bioverge | 08/07/2023 | Republic | $25,000,000 | $138,007 | SAFE | Funded | RegCF |
| Bioverge | 02/28/2022 | Netcapital | $10,014,900 | $710,266 | Equity - Common | Funded | RegCF |
| Bioverge | 05/13/2021 | Netcapital | $10,014,900 | $0 | Equity - Common | Funded | Test the Waters / RegCF |
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Ratings 
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.